Trends & Forecasts

The latest edition of the European Pharmacopoeia was published in July 2016 and some large changes are afoot.

Many people struggle with QbD, but there are secrets to success…

Sitting Down With… Susanne Keitel, Director of the European Directorate for the Quality of Medicines & HealthCare (EDQM) of the Council of Europe in Strasbourg, France.

The pharma industry can succeed post-Brexit if the right policies are put in place.

Researchers call for more oversight as some pharma companies cozy up to hemophilia patients.

The world’s most populous state is set for big things in patented (bio) pharmaceutical development.

A video game built about the pharma industry adds marketing and malpractice capabilities

Ireland can boast of many success stories when it comes to biopharma investment. Here, Barry Heavey from IDA takes us on a tour of recent investments and explains why talent and training are key.

The UK votes to leave the European Union: what happens next, and what are the implications for pharma?

When an industry grows rapidly, innovative approaches are required to ensure sustainable growth. Here, we speak to leaders at Ireland’s National Institute for Bioprocess Research and Training – NIBRT – to find out how a focus on talent, training and technology is changing the face of the field.